Pliant Therapeutics Newsroom

Leerink Partners Maintains Pliant Therapeutics(PLRX.US) With Buy Rating, Maintains Target Price $33

Moomoo NewsNov 19 03:36 ET

Positive Developments in Pliant Therapeutics' IPF Research Bolster Buy Rating

TipRanksNov 19 01:58 ET

A Quick Look at Today's Ratings for Pliant Therapeutics(PLRX.US), With a Forecast Between $32 to $45

Moomoo NewsNov 9 08:10 ET

Pliant Therapeutics Price Target Maintained With a $38.00/Share by HC Wainwright & Co.

Dow JonesNov 8 12:09 ET

Pliant Therapeutics Analyst Ratings

BenzingaNov 8 11:59 ET

RBC Capital Maintains Pliant Therapeutics(PLRX.US) With Buy Rating, Maintains Target Price $45

Moomoo NewsNov 8 07:31 ET

Needham Maintains Pliant Therapeutics(PLRX.US) With Buy Rating, Maintains Target Price $38

Moomoo NewsNov 8 05:37 ET

TD Cowen Maintains Pliant Therapeutics(PLRX.US) With Buy Rating

Moomoo NewsNov 7 23:32 ET

Pliant Therapeutics (PLRX) Receives a Buy From TD Cowen

TipRanksNov 7 22:47 ET

Piper Sandler Maintains Pliant Therapeutics(PLRX.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsSep 17 07:31 ET

Pliant Therapeutics Analyst Ratings

BenzingaSep 13 06:58 ET

H.C. Wainwright Maintains Pliant Therapeutics(PLRX.US) With Buy Rating, Maintains Target Price $38

Moomoo NewsSep 13 06:32 ET

Buy Rating Affirmed for Pliant Therapeutics on Strong Bexotegrast Clinical Data and Broad Therapeutic Potential

TipRanksSep 13 06:28 ET

Leerink Partners Initiates Pliant Therapeutics(PLRX.US) With Buy Rating, Announces Target Price $33

Moomoo NewsSep 9 07:32 ET

Oppenheimer Maintains Pliant Therapeutics(PLRX.US) With Buy Rating, Maintains Target Price $45

Moomoo NewsSep 5 08:31 ET

Oppenheimer Reaffirms Their Buy Rating on Pliant Therapeutics (PLRX)

TipRanksSep 5 07:37 ET

CCORF Maintains Pliant Therapeutics(PLRX.US) With Buy Rating, Maintains Target Price $43

Moomoo NewsAug 15 07:31 ET

Pliant Therapeutics Analyst Ratings

BenzingaAug 12 05:44 ET

Pliant Therapeutics: A Buy Rating on Robust Clinical Progress and Promising Drug Prospects

TipRanksAug 9 05:57 ET

Pliant Therapeutics Analyst Ratings

BenzingaAug 8 05:56 ET